MiR-200c enhances radiosensitivity of human breast cancer cells

Journal of Cellular Biochemistry

Volumn 114, Issue 3, 2013, Pages 606-615

  Lin, Jing ^a   Liu, Cong ^a   Gao, Fu ^a   Mitchel, R E J ^b   Zhao, Luqian ^a   Yang, Yanyong ^a   Lei, Jixiao ^a   Cai, Jianming ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b ATOMIC ENERGY OF CANADA LIMITED   (Canada)

Author keywords

BREAST CANCER; miR 200c; RADIATION THERAPY; RADIOSENSITIVITY; TBK1

Indexed keywords

ANTIMITOTIC AGENT; MICRORNA 200C;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CELL PROLIFERATION; CELL VIABILITY; CLONOGENIC ASSAY; CONTROLLED STUDY; DOUBLE STRANDED DNA BREAK; HUMAN; HUMAN CELL; IONIZING RADIATION; PRIORITY JOURNAL; RADIATION RESPONSE; RADIOSENSITIVITY; REAL TIME POLYMERASE CHAIN REACTION;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DNA BREAKS, DOUBLE-STRANDED; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; MCF-7 CELLS; MICRORNAS; PROTEIN-SERINE-THREONINE KINASES; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS;

EID: 84872815212     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24398     Document Type: Article

References (40)

1. Bartelink H, Horiot JC, Poortmans PM, Struikmans H, Van den Bogaert W, Fourquet A, Jager JJ, Hoogenraad WJ, Oei SB, Warlam-Rodenhuis CC,. 2007. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC22881-1088 2 trial. J Clin Oncol 25: 3259-3265.
2. Bodemann BO, White MA,. 2008. RalGTPases and cancer: Linchpin support of the tumorigenic platform. Nat Rev Cancer 8: 133-140.
3. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, Brabletz T,. 2008. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 9: 582-589.
4. Chen T, Guo J, Yang M, Han C, Zhang M, Chen W, Liu Q, Wang J, Cao X,. 2004. Cyclosporin A impairs dendritic cell migration by regulating chemokine receptor expression and inhibiting cyclooxygenase-2 expression. Blood 103: 413-421.
5. Choi JA, Park MK, Kang CM, Um HD, Bae S, Lee KH, Kim KH, Kim JH, Cho CK, Lee YS, Chung HY, Lee SJ,. 2004. Opposite effects of Ha-Ras and Ki-Ras on radiation-induced apoptosis via differential activation of PI3K/Akt and Rac/p38mitogen-activated protein kinase signaling pathways. Oncogene 23: 9-20.
6. Cochrane DR, Spoelstra NS, Howe EN, Nordeen SK, Richer JK,. 2009. MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule targeting chemotherapeutic agents. Mol Cancer Ther 8: 1055-1066.
7. Cochrane DR, Howe EN, Spoelstra NS, Richer JK,. 2010. Loss of miR-200c: A marker of aggressiveness and chemoresistance in female reproductive cancers. J Oncol 2010: 821717.
8. Daniel R, Ramcharan J, Rogakou E, Taganov KD, Greger JG, Bonner W, Nussenzweig A, Katz RA, Skalka AM,. 2004. Histone H2AX is phosphorylated at sites of retroviral DNA integration but is dispensable for post integration repair. J Biol Chem 279: 45810-45814.
9. Erika VG, Rongmei W, Marion W, Eric FW, Roger PH,. 2007. A highly sensitive RT-PCR method for detection and quantification of microRNAs. Plant Methods 3: 12.
10. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsh M, Fisher ER, Jeong JH, Wolmark N,. 2002. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347: 1233-1241.
11. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T,. 2003. IKK epsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4: 491-496.
12. Foray N, Arlett CF, Malaise EP,. 1997. Radiation-induced DNA double strand breaks and the radiosensitivity of human cells: A closer look. Biochimie 79: 567-575.
13. Gregory JH, Simon DS, Graham JB,. 2006. Potential mRNA degradation targets of hsa-miR-200c identified using informatics and qRT-PCR. Cell Cycle 5: 1951-1956.
14. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ,. 2008. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10: 593-601.
15. Hao J, Zhang S, Zhou Y, Liu C, Hu X,. 2011. MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer. Biochem Biophys Res Commun 406: 552-557.
16. Howe EN, Cochrane DR, Richer JK,. 2011. Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Breast Cancer Res 13: R45.
17. Hurteau GJ, Carlson JA, Spivack SD, Brock GJ,. 2007. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res 67: 7972-7976.
18. Hurteau GJ, Carlson JA, Roos E, Brock GJ,. 2009. Stable expression of miR-200c alone is sufficient to regulate TCF8 (ZEB1) and restore E-cadherin expression. Cell Cycle 8: 2064-2069.
19. Jemal A, Siegel R, Xu J, Ward E,. 2010. Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
20. Kawai T, Akira S,. 2006. Signaling to NF-kappa B by Toll-like receptors. Trends Mol Med 13: 460-469.
21. Kawai T, Akira S,. 2007. TLR signaling. Semin Immunol 19: 24-32.
22. Kong ZL, Xie DX, Thomas B, Pavithra R, Sandeep B, Chen DJ, Amyn AH, Arup C, Hsieh JT, Saha D,. 2010. Downregulation of human DAB2IP gene expression in prostate cancer cells results in resistance to ionizing radiation. Cancer Res 70 (7): 2829-2839.
23. Korherr C, Gille H, Schafer R, Koenig-Hoffmann K, Dixelius J, Egland KA, Pastan I, Brinkmann U,. 2006. Identification of proangiogenic genes and pathways by high-throughput functional genomics: TBK1 and the IRF3 pathway. Proc Natl Acad Sci 103 (11): 4240-4245.
24. Korpal M, Lee ES, Hu G, Kang Y,. 2008. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 283: 14910-14914.
25. Liopoulos D, Lindahl AM, Polytarchou C, Hirsch HA, Tsichlis PN, Struhl K,. 2010. Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells. Mol Cell 39: 761-772.
26. Liu C, Gao F, Li B, Mitchel RE, Liu X, Lin J, Zhao L, Cai J,. 2011a. TLR4 knockout protects mice from radiation-induced thymic lymphoma by downregulation of IL6 and miR-21. Leukemia 25: 1516-1519.
27. Liu C, Li B, Cheng Y, Lin J, Hao J, Zhang S, Mitchel RE, Sun D, Ni J, Zhao L, Gao F, Cai J,. 2011b. miR-21 plays an important role in radiation induced carcinogenesis in BALB/c mice by directly targeting the tumor suppressor gene Big-h3. Int J Biol Sci 7: 347-363.
28. Lou J, Chu G, Zhou G, Jiang J, Huang F, Xu J, Zheng S, Jiang W, Lu Y, Li X, Chen Z, He J,. 2010. Comparison between two kinds of cigarette smoke condensates (CSCs) of the cytogenotoxicity and protein expression in a human B-cell lymphoblastoid cell line using CCK-8 assay, comet assay and protein microarray. Mutat Res 697: 55-59.
29. Magenta A, Cencioni C, Fasanaro P, Zaccagnini G, Greco S, Sarra-Ferraris G, Antonini A, Martelli F, Capogrossi MC,. 2011. miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition. Cell Death Differ 18 (10): 1628-1639.
30. Nunez MI, McMillan TJ, Valenzuela MT, Ruiz de Almodovar JM, Pedraza V,. 1996. Relationship between DNA damage, rejoining and cell killing by radiation in mammalian cells. Radiother Oncol 39: 155-165.
31. Ou YH, Torres M, Ram R, Formstecher E, Roland C, Cheng T, Brekken R, Wurz R, Tasker A, Polvenrino T, Tan SL, White MA,. 2011. TBK1 directly engages Akt/PKB survival signaling to support oncogenic transformation. Mol Cell 41: 458-470.
32. Qian L, Cao F, Cui J, Huang Y, Zhou X, Liu S, Cai J,. 2010a. Radioprotective effect of hydrogen in cultured cells and mice. Free Radic Res 44: 275-282.
33. Qian L, Cao F, Cui JG, Wang Y, Huang Y, Zhao L, Jiang H, Cai J,. 2010b. The potential cardioprotective effects of hydrogen in irradiated mice. J Radiat Res 51: 741-747.
34. Quesne JL, Caldas C,. 2010. Micro-RNAs and breast cancer. Mol Oncol 4: 230-241.
35. Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, Wilson KS, Knowling MA, Coppin CM, Weir L, Gelmon K,. 2005. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97: 116-126.
36. Schickel R, Park SM, Murmann AE, Peter ME,. 2010. miR-200c regulates induction of apoptosis through CD95 by targeting FAP-1. Mol Cell 38: 908-915.
37. Schuurbiers OC, Kaanders JH, van der Heijden HF, Dekhuijzen RP, Oyen WJ, Bussink J,. 2009. The PI3-K/Akt-pathway and radiation resistance mechanisms in Non-small cell lung cancer. J Thorac Oncol 4: 761-767.
38. Shimono Y, Zabala M, Cho RW, Lobo N, Dalerba P, Qian D, Diehn M, Liu H, Panula SP, Chiao E, Dirbas FM, Somlo G, Pera RA, Lao K, Clarke MF,. 2009. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138: 592-603.
39. Taneja N, Davis M, Choy JS, Beckett MA, Singh R, Kron SJ, Weichselbaum RR,. 2004. Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy. J Biol Chem 279: 2273-2280.
40. Zhou CX, Li ZX, Diao HL, Yu YK, Zhu W, Da YY, Chen FF, Yang J,. 2006. DNA damage evaluated by γH2AX foci formation by a selective group of chemical/physical stressors. Mutat Res 604 (1-2): 8-18.